אירובנט
boehringer ingelheim israel ltd. - ipratropium bromide - תמיסה למנשם - ipratropium bromide 0.25 mg/ml - ipratropium bromide
ארלזי 25
novartis israel ltd - etanercept - תמיסה להזרקה - etanercept 25 mg / 0.5 ml - etanercept
ארלזי 50
novartis israel ltd - etanercept - תמיסה להזרקה - etanercept 50 mg / 1 ml - etanercept
ספסמו-ליט 20 מג
megapharm ltd - trospium chloride - טבליות מצופות - trospium chloride 20 mg - trospium - trospium - symptomatic treatment of urge incontinence and /or increased urinary frequency and urgency as may occur in patients with overactive bladder (e.g. idiopathic or neurologic detrusor overactivity) .
נבנק
novartis israel ltd - nepafenac - תרחיף לעין - nepafenac 0.1 % - nepafenac - nepafenac - prevention and treatment of postoperative pain and inflammation associated with cataract surgery and reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.
therapeutic pneumatic compression systems
mego afek ac ltd. - כלל האוכלוסיה - primary lymphedema, secondary lymphedema, venous insufficiency, venous disorders & dysfunction of the muscle pump
הקסאקפרון טבליות
teva israel ltd - tranexamic acid - טבליה - tranexamic acid 500 mg - tranexamic acid - tranexamic acid - treatment of hemorrhage occuring in some forms of surgery, including prostatectomy. hematuria. menorrhagia. hereditary angioneurotic edema.
לוסנטיס
novartis israel ltd - ranibizumab - תמיסה להזרקה - ranibizumab 10 mg/ml - ranibizumab - ranibizumab - treatment of patients with neovascular (wet) age-related macular degeneration (amd).treatment of adult patients with visual impairment due to diabetic macular oedema (dme) .the treatment of visual impairement due to macular oedema secondary to retinal vein occulsion (rvo).the treatment of visual impaiment due to choroidal neovacularization (cnv) secondary to pathologic myopia (pm).
אוזורדקס
abbvie biopharmaceuticals ltd, israel - dexamethasone - שתל במתקן להחדרת תרופה - dexamethasone 0.7 mg - dexamethasone - dexamethasone - ozurdex is indicated for the treatment of adult patients with macular edema following either branch retinal vein occlusion (brvo) or central retinal vein occlusion (crvo).ozurdex is indicated for the treatment of adult patients with inflammation of the posterior segment of the eye presenting as non-infectious uveitis.
ואביסמו
roche pharmaceuticals (israel) ltd - faricimab - תמיסה להזרקה - faricimab 120 mg/ml - faricimab